Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Mar 19, 2007

Eden Biodesign and ImmunoBiology Work on Flu Vaccine

  • Eden Biodesign will provide ImmunoBiology with a range of development and manufacturing services for its vaccine program that targets both seasonal and pandemic flu.

    “Working with Eden Biodesign will allow us to rapidly advance the next generation influenza vaccine forward towards a clinical trial application and is consistent with our aggressive timelines for bringing our viral lead product to the clinic,” says Graham Clarke, CEO of ImmunoBiology. 

    Eden Biodesign is the operator of the National Biomanufacturing Center (NBC) facility.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »